Literature DB >> 11557140

Survival of nontypeable Haemophilus influenzae in macrophages.

J E Craig1, A Cliffe, K Garnett, N J High.   

Abstract

In this study we have investigated the ability of nonencapsulated, nontypeable Haemophilus influenzae, NT477 to survive in the J774 mouse macrophage-like cell line. Viable, intracellular nontypeable H. influenzae could still be recovered from macrophages 72 h after phagocytosis. In contrast, H. influenzae strain Rd, an avirulent, nonencapsulated variant of a serotype d strain, was killed within 24 h. These differences suggest that NT477, in comparison to Rd, possesses unique attributes that enable it to survive in macrophages for prolonged periods. To determine whether this trait is ubiquitous amongst nontypeable H. influenzae, 33 primary clinical isolates obtained from children with otitis media were screened for their ability to survive in macrophages. Of these isolates, 82% were able to persist in an intracellular environment for periods of at least 24 h. The number of viable organisms recovered at this time ranged from 2x10(4) to 50 colony-forming units per strain indicating that the extent to which nontypeable H. influenzae can resist macrophage-mediated killing varies between strains.

Entities:  

Mesh:

Year:  2001        PMID: 11557140     DOI: 10.1111/j.1574-6968.2001.tb10820.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  29 in total

1.  Overlapping and complementary oxidative stress defense mechanisms in nontypeable Haemophilus influenzae.

Authors:  Alistair Harrison; Beth D Baker; Robert S Munson
Journal:  J Bacteriol       Date:  2014-11-03       Impact factor: 3.490

2.  Systemic humoral immunity to non-typeable Haemophilus influenzae.

Authors:  P T King; J Ngui; D Gunawardena; P W Holmes; M W Farmer; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

Review 3.  Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Christian P Ahearn; Mary C Gallo; Timothy F Murphy
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

4.  The extracytoplasmic sigma factor, final sigma(E), is required for intracellular survival of nontypeable Haemophilus influenzae in J774 macrophages.

Authors:  Jane E Craig; Angela Nobbs; Nicola J High
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease.

Authors:  Charles S Berenson; Catherine T Wrona; Lori J Grove; Jane Maloney; Mary Alice Garlipp; Paul K Wallace; Carleton C Stewart; Sanjay Sethi
Journal:  Am J Respir Crit Care Med       Date:  2006-03-30       Impact factor: 21.405

6.  Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines.

Authors:  Charles S Berenson; Timothy F Murphy; Catherine T Wrona; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

7.  Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease.

Authors:  Charles S Berenson; Ragina L Kruzel; Ellana Eberhardt; Sanjay Sethi
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

8.  Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke.

Authors:  Pau Martí-Lliteras; Verónica Regueiro; Pau Morey; Derek W Hood; Carles Saus; Jaume Sauleda; Alvar G N Agustí; José Antonio Bengoechea; Junkal Garmendia
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

9.  Glutathione-dependent alcohol dehydrogenase AdhC is required for defense against nitrosative stress in Haemophilus influenzae.

Authors:  Stephen P Kidd; Donald Jiang; Michael P Jennings; Alastair G McEwan
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

10.  Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.

Authors:  Ofir Menashe; Elena Kaganskaya; Timor Baasov; Sima Yaron
Journal:  Antimicrob Agents Chemother       Date:  2008-01-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.